Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Dec 03 2020
Published Dec 3 2020
4 min read

Press Release Dec 03 2020

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 03, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Metolazone Tablets USP 2.5 mg, 5 mg, and 10 mg.".

View Attachment